Ellen Schultz, Gillian D. Sanders, PR Trotter, EF Jr Patz, GA Silvestri, Douglas K. Owens, Michael K. Gould
Background: Effective strategies for managing patients with solitary pulmonary nodules (SPN) depend critically on the pre-test probability of malignancy.
Michael K. Gould, Gillian D. Sanders, Paul G. Barnett, C Rydzak, CC Maclean, Mark B. McClellan, Douglas K. Owens
BACKGROUND: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) is a potentially useful but expensive test to diagnose solitary pulmonary nodules.
OBJECTIVE: To compare the probability of cancer in a solitary pulmonary nodule using standard criteria with Bayesian analysis and result of 2- [F-18] fluoro-2-deoxy-D-glucose-positron emission...